DiabetesDevelopmental BiologyPeer-reviewed journal article
The Anna Karenina model of beta cell maturation in development and their dedifferentiation in type 1 and type 2 diabetes
Sutichot D. NimkulratiD, Matthew N. BernsteiniD, Zijian NiiD, Jared BrowniD, Christina M. KendziorskiiD, Barak BlumiD
Abstract
Loss of mature {beta} cell function and identity, or {beta} cell dedifferentiation, is seen in all types of diabetes mellitus. Two competing models explain {beta} cell dedifferentiation in diabetes. In the first model, {beta} cells dedifferentiate in the reverse order of their developmental ontogeny. This model predicts that dedifferentiated {beta} cells resemble {beta} cell progenitors. In the second model, {beta} cell dedifferentiation depends on the type of diabetogenic stress. This model, which we call the "Anna Karenina" model, predicts that in each type of diabetes, {beta} cells dedifferentiate in their own way, depending on how their mature identity is disrupted by any particular diabetogenic stress. We directly tested the two models using a {beta} cell-specific lineage-tracing system coupled with RNA-sequencing in mice. We constructed a multidimensional map of {beta} cell transcriptional trajectories during the normal course of {beta} cell postnatal development and during their dedifferentiation in models of both type 1 diabetes (NOD) and type 2 diabetes (BTBR-Lepob/ob). Using this unbiased approach, we show here that despite some similarities between immature and dedifferentiated {beta} cells, {beta} cells dedifferentiation in the two mouse models is not a reversal of developmental ontogeny and is different between different types of diabetes.
- organism: mouse
- assay: bulk RNA-seq
- research focus: clustering
- research focus: trajectory inference
- research focus: differential expression
- approach: statistical model
- Citations
- 19
- FWCI
- 3.52
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Developmental control of DNA damage responses in α- and β-cells shapes the selective beta-cell susceptibility in diabetes
Sneha S. Varghese, Alessandro Giovanni Hernandez-De La Peña, … Sangeeta Dhawan·DiabetesPeer-reviewed·Jul 15, 2026
- AFF3 and BACH2 are master regulators of metabolic inflexibility, β/α-cell transition, and dedifferentiation in type 2 diabetes
J. Son, H. Ding, … A. Califano·bioRxiv·Sep 12, 2019
- β-cell dedifferentiation is associated with epithelial-mesenchymal transition triggered by miR-7-mediated repression of mSwi/Snf complex
Tracy C S Mak, Yorrick von Ohlen, … Mathieu Latreille·bioRxiv·Oct 1, 2019
- DNA damage models phenotypes of beta cell senescence in Type 1 Diabetes
G. Brawerman, J. Pipella, P. J. Thompson·bioRxiv·Jun 7, 2021
- Compromised beta-cell identity in type 2 diabetes
Pritha Dutta, Nadège Merabet, … Peter M. A. Sloot·bioRxiv·Mar 20, 2023
- Delineating mouse β-cell identity during lifetime and in diabetes with a single cell atlas
Karin Hrovatin, Aimée Bastidas-Ponce, … Fabian Joachim Theis·Nature MetabolismPeer-reviewed·Sep 11, 2023